Body distribution of polysorbate-80 and doxorubicin-loaded [14C]poly(butyl cyanoacrylate) nanoparticles after i.v. administration in rats

Journal of Drug Targeting

Volumn 13, Issue 10, 2005, Pages 535-542

  Ambruosi, Alessandra ^a   Yamamoto, Hiromitsu ^b   Kreuter, Jörg ^a  

^a GOETHE UNIVERSITY   (Germany)

^b GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Blood brain barrier; Doxorubicin; Nanoparticles; Polysorbate 80

Indexed keywords

CARBON 14; DOXORUBICIN; ENBUCRILATE; NANOPARTICLE; POLYSORBATE 80;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BODY DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BRAIN LEVEL; DRUG TISSUE LEVEL; ISOTOPE LABELING; MATERIAL COATING; NONHUMAN; PRIORITY JOURNAL; RADIOACTIVITY; RAT; RETICULOENDOTHELIAL SYSTEM;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BLOOD-BRAIN BARRIER; CARBON RADIOISOTOPES; DOXORUBICIN; DRUG CARRIERS; ENBUCRILATE; INJECTIONS, INTRAVENOUS; NANOSTRUCTURES; POLYSORBATES; RATS; RATS, WISTAR; TISSUE DISTRIBUTION;

EID: 30844462755     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.1080/10611860500411043     Document Type: Article

References (34)

1. Alyautdin, RN and Gothier, D and Petrov, V and Kharkevich, D and Kreuter, J. (1995) Analgesic activity of the hexapeptide dalargin absorbed on the surface of polysorbate 80-coated poly(butylcyanoacrylate) nanoparticles Eur J Pharm Biopharm, 41, pp. 44-48.
2. Alyautdin, RN and Petrov, VE and Langer, K and Berthold, A and Kharkevich, DA and Kreuter, J. (1997) Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles Pharm Res, 14, pp. 325-328.
3. Alyautdin, RN and Tezikov, EB and Ramge, P and Kharkevich, DA and Begley, DJ and Kreuter, J. (1998) Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: An in situ brain perfusion study J Microencapsul, 15, pp. 67-74.
4. Alyautdin, RN and Reichel, A and Löbenberg, R and Ramge, P and Kreuter, J and Begley, DJ. (2001) Interaction of poly-(butylcyanoacrylate) nanoparticles with the blood-brain barrier in vivo and in vitro J Drug Target, 9, pp. 209-221.
5. Behan, N and Birkinshaw, C and Clarke, N. (2001) Poly n-butyl cyanoacrylate nanoparticles: A mechanistic study of polymerisation and particle formation Biomaterials, 22, pp. 1335-1344.
6. Brigger, I and Dubernet, C and Couvreur, P. (2002) Nanoparticles in cancer therapy and diagnosis Adv Drug Deliv Rev, 54, pp. 631-651.
7. Brigger, I and Morizet, J and Couvreur, P. (2004) Negative preclinical results with stealth nanospheres-encapsulated doxorubicin in an orthotopic murine brain tumor model J Control Release, 100, pp. 29-40.
8. Borchard, G and Kreuter, J. (1993) Interaction of serum components with poly(methylmethacrylate) nanoparticles and the resulting body distribution after intravenous injection in rats J Drug Target, 1, pp. 15-19.
9. de Verdiere, AC and Dubernet, C and Nemati, F and Soma, E and Appel, M and Ferte, J and Bernard, S and Puisieux, F and Couvreur, P. (1997) Reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: Towards a mechanism of action Br J Cancer, 76, pp. 198-205.
10. Gipps, EM and Arshady, R and Kreuter, J and Groscurth, P and Speiser, PP. (1986) Distribution of polyhexyl cyanoacrylate nanoparticles in nude mice bearing human osteosarcoma J Pharm Sci, 75, pp. 256-258.
11. Gipps, EM and Groscurth, P and Kreuter, J and Speiser, PP. (1988) Distribution of polyhexylcyanoacrylate nanoparticles in nude mice over extended times and after repeated injection J Pharm Sci, 77, pp. 208-209.
12. Granholm, AC and Albeck, D and Backman, C and Curtis, M and Ebendal, T and Friden, P and Henry, M and Hoffer, B and Kordower, J and Rose, GM and Soderstrom, S and Bartus, RT. (1998) A non-invasive system for delivering neural growth factors across the blood-brain barrier: A review Rev Neurosci, 9, pp. 31-55.
13. Gulyaev, AE and Gelperina, SE and Skidan, IN and Antropov, AS and Kivman, GY and Kreuter, J. (1999) Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles Pharm Res, 16, pp. 1564-1569.
14. Hu, YP and Jarillon, S and Dubernet, C and Couvreur, P and Robert, J. (1996) On the mechanism of action of doxorubicin encapsulation in nanospheres for the reversal of multidrug resistance Cancer Chemother Pharmacol, 37, pp. 556-560.
15. Kreuter, J. (1983a) Evaluation of nanoparticles as drug-delivery systems II: Comparison of the body distribution of nanoparticles with the body distribution of microspheres (diameter greater than 1 micron), liposomes, and emulsions Pharm Acta Helv, 58, pp. 217-226.
16. Kreuter, J. (1983b) Evaluation of nanoparticles as drug-delivery system I: Preparation methods Pharm Acta Helv, 58, pp. 196-209.
17. Kreuter, J. (1983c) Physicochemical characterization of polyacrylic nanoparticles Int J Pharm, 14, pp. 43-58.
18. Kreuter, J and Alyautdin, RN and Kharkevich, DA and Ivanov, AA. (1995) Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles) Brain Res, 674, pp. 171-174.
19. Kreuter, J. (2001) Nanoparticulate systems for brain delivery of drugs Adv Drug Deliv Rev, 47, pp. 65-81.
20. Kreuter, J and Shamenkov, D and Petrov, V and Ramge, P and Cychutek, K and Koch-Brandt, C and Alyautdin, R. (2002) Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier J Drug Target, 10, pp. 317-325.
21. Lockman, PR and Mumper, RJ and Khan, MA and Allen, DD. (2002) Nanoparticle technology for drug delivery across the blood-brain barrier Drug Dev Ind Pharm, 28, pp. 1-13.
22. Lück M. 1997. Plasmaproteinadsorption als möglicher Schlüsselfaktor für eine kontrollierte Arzneistoffapplikation mit partikulären Trägern. PhD thesis, Freie Universität Berlin, pp. 14-24, 137-154.
23. Neuwelt, EA and Barnett, PA and Hellstrom, KE and Hellstrom, I and McCormick, CI and Ramsey, FL. (1994) Effect of blood-brain barrier disruption on intact and fragmented monoclonal antibody localization in intracerebral lung carcinoma xenografts J Nucl Med, 35, pp. 1831-1841.
24. Pardridge, WM. (1991) Peptide drug delivery to the brain. New York: Raven Press.
25. Pardridge, WM. (2003) Blood-brain barrier drug targeting: The future of brain drug development Mol Interv, 3, pp. 90-105, 51.
26. Roullin, VG and Deverre, JR and Lemaire, L and Hindre, F and Venier-Julienne, MC and Vienet, R and Benoit, JP. (2002) Anti-cancer drug diffusion within living rat brain tissue: An experimental study using [(3)H](6)-5-fluorouracil-loaded PLGA microspheres Eur J Pharm Biopharm, 53, pp. 293-299.
27. Steiniger, SC and Kreuter, J and Khalansky, AS and Skidan, IN and Bobruskin, AI and Smirnova, ZS and Severin, SE and Uhl, R and Kock, M and Geiger, KD and Gelperina, SE. (2004) Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles Int J Cancer, 109, pp. 759-767.
28. Schröder, U and Sabel, BA. (1996) Nanoparticles, a drug carrier system to pass the blood-brain barrier, permit central analgesic effects of i.v. dalargin injections Brain Res, 710, pp. 121-124.
29. Schröder, U and Sommerfeld, P and Ulrich, S and Sabel, BA. (1998) Nanoparticle technology for delivery of drugs across the blood-brain barrier J Pharm Sci, 87, pp. 1305-1307.
30. Tsuji, A. (2000) The specific mechanism for transporting drugs into the brain blood-brain barrier and the drug delivery to the CNS. New York: Marcel Dekker. Secific mechanism forortgs drugs to the bta
31. Tröster, SD and Müller, U and Kreuter, J. (1990) Modification of the body distribution of poly(methyl methacrylate) nanoparticles in rats by coating with surfactants Int J Pharm, 61, pp. 85-100.
32. Tröster, SD and Kreuter, J. (1992) Influence of the surface properties of low contact angle surfactants on the body distribution of 14C-poly(methyl methacrylate) nanoparticles J Microencapsul, 9, pp. 19-28.
33. von Heijne, G and Gavel, Y. (1988) Topogenic signals in integral membrane proteins Eur J Biochem, 174, pp. 671-678.
34. von Heijne, G. (1992) Membrane protein structure prediction. Hydrophobicity anlysis and the positive-inside rule J Mol Biol, 225, pp. 487-494.